US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 0.262
  • +0.012+4.97%
Close Dec 18 16:00 ET
  • 0.235
  • -0.027-10.34%
Pre 05:19 ET
14.38MMarket Cap-0.15P/E (TTM)

About Cara Therapeutics Company

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.

Company Profile

SymbolCARA
Company NameCara Therapeutics
Listing DateJan 31, 2014
Issue Price11.00
Founded2004
CEOMr. Christopher A. Posner
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address400 Atlantic Street,Suite 500
CityStamford
ProvinceConnecticut
CountryUnited States of America
Zip Code06901
Phone1-203-406-3700

Company Executives

  • Name
  • Position
  • Salary
  • Christopher A. Posner
  • President, Chief Executive Officer and Director
  • 2.92M
  • Ryan D. Maynard
  • Chief Financial Officer and Principal Accounting Officer
  • 1.24M
  • Scott M. Terrillion
  • General Counsel, Secretary and Chief Compliance Officer
  • --
  • Martin A. Vogelbaum
  • Chairman of the Board
  • 519.99K
  • Dr. Susan Shiff, M.B.A.,PhD
  • Independent Director
  • 262.49K
  • Dr. Jeffrey L. Ives, PhD
  • Independent Director
  • 272.49K
  • Helen M. Boudreau, M.B.A.
  • Independent Director
  • 376.01K
  • Dr. Lisa von Moltke, M.D.
  • Independent Director
  • 254.99K
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.